Author

S. Y. Chang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Ianevski· 1 shared A. L. P. H. d'Alexandry d'Orengiani· 1 shared D. Kainov· 1 shared D. Shum· 1 shared I. Choi· 1 shared J.-Y. Min· 1 shared M. Ko· 1 shared M. P. Windisch· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ianevski

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19

M. Ko, S. Y. Chang, S. Y. Byun, A. Ianevski, I. Choi, A. L. P. H. d'Alexandry d'Orengiani, D. Kainov, D. Shum, J.-Y. Min, M. P. Windisch

The paper screens FDA-approved drugs against a MERS-CoV isolate to identify potential therapies for COVID-19, finding several drugs with therapeutic indexes >6 and synergistic combinations.

bioRxiv · Feb 25, 2020Microbiology